Sharekhan has given Buy recommendation for Ashok Leyland with a target price of Rs. 151 in its research report issued on Feb 12, 2021
Sharekhan’s research report on Ashok Leyland
ALL’s Q3FY21 results were below expectations, mainly due to lower than expected recovery in EBITDA margins. We expect ALL’s profitability to improve significantly, with its EBITDA growing at 157% CAGR for FY2021-23E. Despite the run up in the stock, it is still available below its historical average multiples. The stock is trading at P/E of 18.3x and EV/EBITDA of 10.2x its FY2023E estimates. We retain our Buy rating on the stock.
We reiterate our Buy rating on Ashok Leyland Limited (ALL) with a revised PT of Rs 151, owing to faster than expected recovery in macro-economic activities, leading to benefits in the CV industry.